RE:Calfrac way undervalued!I agree, calfrac look interesting now.I have been losely following this since summer of 2015. Haven't made my mind yet as I am still going through the stack of their papers. So far CFW been a one hell of a consistent cash burner, and I wonder if the recent blood transfusion will change anything. The exercizable set price of 2.5$ in 2023 for such a possible flood look scary, and I have seen this happen before, this maybe a major obstacle for retail investor's future valuations. Apart from that, even if I don't find anything obviously wrong, I will wait for any sign of balance sheet improvement before entering this one. Might be another year, but worth the wait. My 2c